Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4677 results

Sort By:

A Novel Imaging Modality to Evaluate Radiation-Induced Uterine Injury

Study ID: NCT06518174
Start Date: 2025-06-01
End Date: 2027-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

22

Intervention / Treatment

MRI, SWE, and US evaluation

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Menopausal HT for Women Living With HIV (HoT)

Study ID: NCT06856174
Start Date: 2025-06-18
End Date: 2026-10-19
Study Type

Interventional

Study Phase

Phase4

No. of Participants

105

Intervention / Treatment

Transdermal estradiol gel

Micronized Progesterone

Placebo for estradiol gel

Placebo for micronized progesterone

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Source: clinicaltrials.gov

Share:
Add to list

This Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab Checkpoint Inhibitor Immunotherapy Infusions in Patients With Metastatic Non-small Cell Lung Cancer

Study ID: NCT06882174
Start Date: 2025-10-06
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

58

Intervention / Treatment

Scheduling of the time of pembrolizumab infusions

Sponsor

AHS Cancer Control Alberta

Source: clinicaltrials.gov

Share:
Add to list

Stemchymal® for Polyglutamine Spinocerebellar Ataxia

Study ID: NCT06397274
Start Date: 2025-06-01
End Date: 2028-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Stemchymal

Placebo

Sponsor

Steminent US, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Trifecta Research Study

Study ID: NCT06810765
Start Date: 2025-05
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Hormone Replacement Therapy (HRT)

Magnetic Resonance Therapy (MeRT)

ibogaine with magnesium treatment

5-MeO-DMT

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Abscopal Effect from Low-dose Radiotherapy in Metastatic Cancer Combined with Stereotactic Body Radiotherapy

Study ID: NCT05578274
Start Date: 2025-06
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

186

Intervention / Treatment

SBRT + LDRT

SBRT alone

Sponsor

Soonchunhyang University Hospital

Source: clinicaltrials.gov

Share:
Add to list

Early-feasibility Study to Evaluate Usability and Safety of the Watch-Transcutaneous Electrical Acustimulation (TEA) Device

Study ID: NCT06366074
Start Date: 2025-10
End Date: 2026-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Watch-TEA group

Tethered TEA device

Sponsor

University of Michigan

Source: clinicaltrials.gov

Share:
Add to list

Social Cognition in Dystrophinopathies and Neurodevelopmental Disorders

Study ID: NCT06874166
Start Date: 2025-09
End Date: 2027-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

45

Intervention / Treatment

Electroencephalography (EEG)

Social Cognition Tasks

Sponsor

IRCCS Eugenio Medea

Source: clinicaltrials.gov

Share:
Add to list

Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease

Study ID: NCT06711666
Start Date: 2025-05
End Date: 2027-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

87

Intervention / Treatment
Sponsor

National Institute of Health and Medical Research, France

Source: clinicaltrials.gov

Share:
Add to list

Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia

Study ID: NCT06547866
Start Date: 2025-06-01
End Date: 2031-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

102

Intervention / Treatment

zanubrutinib + BGB-11417

Sponsor

French Innovative Leukemia Organisation

Source: clinicaltrials.gov

Share:
Add to list